Medicine News and Research

RSS

Johns Hopkins scientists develop mouse model for autism spectrum disorders

In an effort to unravel the tangled biology of autism, Johns Hopkins scientists have created a mouse model that mimics a human mutation of a gene known to be associated with autism spectrum disorders.

21 Jun 2011

Rheonix, Mayo Clinic partner for genotyping test to assist warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings.

21 Jun 2011

New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women

Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the National Institutes of Health-funded Microbicide Trials Network.

21 Jun 2011

Roundup: State employee benefit battles heat up; Wis. Gov. to remake Medicaid program; Mass. cost controls

The Legislature is close to wrapping up its work on the $25 billion state budget bill after the Senate made minor changes to the plan late Sunday before approving it by a lopsided margin. ... the spending plan for the budget year that starts July 1 would eliminate more than 2,000 state jobs and includes cuts in most state departments and agencies.

21 Jun 2011

Mayo Clinic announces collaboration on genotyping test for Warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings. The genotyping test will be available for all patients of Mayo Clinic and is the subject of ongoing research for improved anticoagulation therapy. Additionally, the test will be offered through Mayo Clinic’s reference laboratory, Mayo Medical Laboratories, to clients throughout the world.

20 Jun 2011

Wells Fargo Insurance Services and ImPACT Applications, Inc. develops innovative concussion care program

Wells Fargo & Company’s (NYSE: WFC) Student Insurance Division and ImPACT Applications have joined forces to launch Play It Safe Concussion CareSM - a new concussion management treatment and services solution for youth athletes nationwide. The program provides concussion medical expense benefits for athletes who sustain a covered head injury. An innovative approach to concussion management, Play It Safe Concussion Care provides education, neurocognitive testing, access to medical professionals who are credentialed ImPACT (Immediate Post-concussion Assessment and Cognitive Testing), consultants, and excess insurance coverage to protect the financial well-being of youth athletes and their families.

20 Jun 2011

Baptist Health System to open four new emergency hospitals in Alamo City

Baptist Health System, San Antonio's healthcare leader for more than a century, plans to open four new emergency hospitals in the Alamo City, bringing emergency medical care closer to home for many residents. The hospital system is partnering with emergency medicine pioneer Emerus to manage the facilities based on the company's successful model in other cities throughout Texas.

20 Jun 2011

Hardin Memorial Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Hardin Memorial Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

20 Jun 2011

Meditation increases concentration and decreases stress

The nation's current healthcare crisis has added a new dimension to the old saying, "Prevention is the best medicine." With rising co-pays, high deductibles, confusion over coverage, and prescription drug headaches, healthcare consumers recognize that getting sick is more complicated than ever.

20 Jun 2011

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.

20 Jun 2011

SAIC receives USAMRMC contract to provide CDMRP with scientific services

Science Applications International Corporation announced today it was awarded a follow-on contract by the U.S. Army Medical Research and Materiel Command (USAMRMC) to provide scientific and other support services to the Congressionally Directed Medical Research Programs.

20 Jun 2011

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Chengdu Tianyin files renewal application for High Tech Enterprise Status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.

20 Jun 2011

Researchers identify nine blood proteins that alter with age

Loss of muscle mass is not only associated with disease, such as HIV and cancer, but also with the normal aging process. Anabolic steroids are sometimes used to reverse loss of lean muscle tissue but they can have unwanted side effects.

20 Jun 2011

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

A single gene is central in the development of several forms of polycystic kidney and liver disease, Yale School of Medicine researchers report in the June 19 issue of Nature Genetics.

20 Jun 2011

University of Texas professor recommends three postulates to find probable cause of AD

After more than 100 years following its pathologic description, the cause of Alzheimer's disease (AD) remains unknown. To test the validity of present and future proposals related to the probable cause of AD, three postulates, or necessary conditions, are recommended by Jack de la Torre, MD, PhD, Adjunct Professor of Psychology at the University of Texas, Austin, in an article published in the Journal of Alzheimer's Disease.

20 Jun 2011